X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with J.B.Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs J.B.CHEMICALS - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD J.B.CHEMICALS STRIDES SHASUN LTD/
J.B.CHEMICALS
 
P/E (TTM) x 15.2 15.9 95.4% View Chart
P/BV x 1.8 2.5 69.9% View Chart
Dividend Yield % 0.6 0.2 365.3%  

Financials

 STRIDES SHASUN LTD   J.B.CHEMICALS
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
J.B.CHEMICALS
Mar-16
STRIDES SHASUN LTD/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs1,275318 400.7%   
Low Rs918200 460.2%   
Sales per share (Unadj.) Rs389.6148.0 263.3%  
Earnings per share (Unadj.) Rs28.019.1 146.6%  
Cash flow per share (Unadj.) Rs48.923.9 204.2%  
Dividends per share (Unadj.) Rs4.500.50 900.0%  
Dividend yield (eoy) %0.40.2 212.5%  
Book value per share (Unadj.) Rs303.1128.9 235.1%  
Shares outstanding (eoy) m89.4284.82 105.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.7 160.9%   
Avg P/E ratio x39.213.6 289.1%  
P/CF ratio (eoy) x22.410.8 207.5%  
Price / Book Value ratio x3.62.0 180.2%  
Dividend payout %16.12.6 614.1%   
Avg Mkt Cap Rs m98,03621,951 446.6%   
No. of employees `0005.82.7 212.1%   
Total wages/salary Rs m5,8811,841 319.4%   
Avg. sales/employee Rs Th6,005.94,590.9 130.8%   
Avg. wages/employee Rs Th1,014.0673.4 150.6%   
Avg. net profit/employee Rs Th431.2592.1 72.8%   
INCOME DATA
Net Sales Rs m34,83412,551 277.5%  
Other income Rs m1,686542 311.3%   
Total revenues Rs m36,52013,093 278.9%   
Gross profit Rs m6,4282,055 312.8%  
Depreciation Rs m1,872412 453.8%   
Interest Rs m2,26996 2,371.3%   
Profit before tax Rs m3,9732,088 190.3%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m470469 100.2%   
Profit after tax Rs m2,5011,619 154.5%  
Gross profit margin %18.516.4 112.7%  
Effective tax rate %11.822.5 52.7%   
Net profit margin %7.212.9 55.7%  
BALANCE SHEET DATA
Current assets Rs m38,1657,778 490.7%   
Current liabilities Rs m30,4024,358 697.6%   
Net working cap to sales %22.327.2 81.8%  
Current ratio x1.31.8 70.3%  
Inventory Days Days7755 141.5%  
Debtors Days Days10480 130.5%  
Net fixed assets Rs m37,6395,713 658.9%   
Share capital Rs m894170 527.2%   
"Free" reserves Rs m26,21010,547 248.5%   
Net worth Rs m27,10510,937 247.8%   
Long term debt Rs m16,3770-   
Total assets Rs m81,16815,574 521.2%  
Interest coverage x2.822.8 12.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.8 53.3%   
Return on assets %5.911.0 53.4%  
Return on equity %9.214.8 62.3%  
Return on capital %12.120.0 60.4%  
Exports to sales %048.7 0.0%   
Imports to sales %07.1 0.0%   
Exports (fob) Rs mNA6,115 0.0%   
Imports (cif) Rs mNA889 0.0%   
Fx inflow Rs m13,4656,169 218.3%   
Fx outflow Rs m4,0761,285 317.1%   
Net fx Rs m9,3894,884 192.3%   
CASH FLOW
From Operations Rs m2,8811,397 206.3%  
From Investments Rs m-7,051-320 2,201.4%  
From Financial Activity Rs m3,382-1,196 -282.8%  
Net Cashflow Rs m-788-102 769.9%  

Share Holding

Indian Promoters % 27.7 55.4 50.0%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 37.8 3.4 1,115.0%  
FIIs % 8.6 3.9 220.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 37.0 70.0%  
Shareholders   56,241 30,437 184.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 22, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS